Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants

JAMA

Volumn 305, Issue 6, 2011, Pages 576-584

  Jones, Christine E ^a,b   Naidoo, Shalena ^d   De Beer, Corena ^d,e   Esser, Monika ^d,e   Kampmann, Beate ^a,b,c   Hesseling, Anneke C ^d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Medical Research Council   (Gambia)

^d STELLENBOSCH UNIVERSITY   (South Africa)

^e STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS B SURFACE ANTIGEN; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; TETANUS ANTIBODY; TETANUS TOXOID;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BIRTH; BORDETELLA PERTUSSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MATERNAL DISEASE; PLACENTAL TRANSFER; PRIORITY JOURNAL; SOUTH AFRICA; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 79751505428     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.100     Document Type: Article

References (41)

1. Black RE, Cousens S, Johnson HL, et al; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375(9730):1969- 1987.
2. Duclos P, Okwo-Bele J-M, Gacic-Dobo M, Cherian T. Global immunization: status, progress, challenges and future. BMC Int Health Hum Rights. 2009;9(suppl 1):S2.
3. Cáceres VM, Strebel PM, Sutter RW. Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis. 2000;31(1):110-119. (Pubitemid 32268948)
4. Cumberland P, Shulman CE, Maple PAC, et al. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis. 2007;196(4):550-557. (Pubitemid 47206101)
5. Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis. 2004;190(2):335-340. (Pubitemid 38951975)
6. Ned RM, Price AE, Crawford SB, et al. Effect of placental malaria and HIV infection on the antibody responses to Plasmodium falciparum in infants. J Infect Dis. 2008;198(11):1609-1619.
7. de Moraes-Pinto MI, Verhoeff F, Chimsuku L, et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed. 1998;79(3):F202-F205. (Pubitemid 28500677)
8. Albrecht P, Ennis FA, Saltzman EJ, Krugman S. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr. 1977;91(5):715-718. (Pubitemid 8207589)
9. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic: 2010. http://www.unaids.org/en/media/ unaids/contentassets/documents/unaidspublication/2010/20101123-globalreport-en. pdf. Accessed January 14, 2011.
10. Marinda E, Humphrey JH, Iliff PJ, et al; ZVITAMBO Study Group. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J. 2007;26(6):519-526. (Pubitemid 46847314)
11. Kuhn L, Kasonde P, Sinkala M, et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis. 2005;41(11):1654-1661. (Pubitemid 41691606)
12. McNally LM, Jeena PM, Gajee K, et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet. 2007;369(9571):1440-1451. (Pubitemid 46635781)
13. Koyanagi A, Humphrey JH, Ntozini R, et al; ZVITAMBO Study Group. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J. 2011;30(1):45-51.
14. Médecins Sans Frontières, Western Cape Province Department of Health, City of Cape Town Department of Health, University of Cape Town Centre for Infectious Disease Epidemiology and Research. Providing HIV/TB Care at the Primary Health Care Level: Khayelitsha Annual Activity Report: 2008-2009. http://www.msf.org.za/Docs/Khayelitsha/Khayelitsha-Report-2008-2009.pdf. Accessed October 11, 2010.
15. Médecins Sans Frontières, Western Cape Province Department of Health, City of Cape Town Department of Health, University of Cape Town Centre for Infectious Disease Epidemiology and Research. Comprehensive TB/HIV Services at Primary Health Care Level: Khayelitsha Annual Activity Report: 2007-2008. http://www.msf.org.za/docs/Khayelitsha/2007-2008-Annual-Activity- Report-August-2008.pdf. Accessed October 11, 2010.
16. World Health Organization. Revised BCG vaccination guidelines for infants at risk for HIV infection. Wkly Epidemiol Rec. 2007;82(21):193-196.
17. Hesseling AC, Johnson LF, Jaspan H, et al. Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants. Bull World Health Organ. 2009;87(7):505-511.
18. Nuttall JJ, Davies M-A, Hussey GD, Eley BS. Bacillus Calmette- Guérin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy. Int J Infect Dis. 2008;12(6):e99-e105.
19. Musher DM, Luchi MJ, Watson DA, Hamilton R, Baughn RE. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis. 1990;161(4):728-735. (Pubitemid 20120232)
20. Agbarakwe AE, Griffiths H, Begg N, Chapel HM. Avidity of specific IgG antibodies elicited by immunisation against Haemophilus influenzae type b. J Clin Pathol. 1995;48(3):206-209.
21. World Health Organization. Tetanus vaccine. Wkly Epidemiol Rec. 2006;81(20):198-208.
22. Farquhar C, Nduati R, Haigwood N, et al. High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody. J Acquir Immune Defic Syndr. 2005;40(4):494-497. (Pubitemid 41669186)
23. Scott S, Cumberland P, Shulman CE, et al. Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples. J Infect Dis. 2005;191(11):1854-1860. (Pubitemid 40705392)
24. Madhi SA, Kuwanda L, Saarinen L, et al. Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children. Vaccine. 2005;23(48-49):5517-5525. (Pubitemid 41608600)
25. Madhi SA, Adrian P, Cotton MF, et al; Comprehensive International Program of Research on AIDS 4 Study Team. Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants. J Infect Dis. 2010;202(3):355-361.
26. Madhi SA, Kuwanda L, Cutland C, Holm A, Käyhty H, Klugman KP. Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J. 2005;24(5):410-416. (Pubitemid 40664235)
27. Nair N, Moss WJ, Scott S, et al. HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection. J Infect Dis. 2009;200(7):1031-1038.
28. Scott S, Moss WJ, Cousens S, et al. The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis. 2007;45(11):1417-1424. (Pubitemid 351411869)
29. Sarvas H, Kurikka S, Seppälä IJ, Mäkelä PH, Mäkelä O. Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants. J Infect Dis. 1992;165(5):977-979.
30. Siegrist CA. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine. 2003;21(24):3406-3412.
31. Kurikka S, Olander RM, Eskola J, Käyhty H. Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy. Pediatr Infect Dis J. 1996;15(6):530-535. (Pubitemid 26187799)
32. Plotkin SA. Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis. 2008;47(3):401-409.
33. Influenza vaccines. Wkly Epidemiol Rec. 2005;80(33):279-287.
34. Centers for Disease Control and Prevention (CDC). Influenza vaccination in pregnancy: practices among obstetrician-gynecologists - United States, 2003-04 influenza season. MMWR Morb Mortal Wkly Rep. 2005;54(41):1050-1052.
35. Healy CM, Baker CJ. Prospects for prevention of childhood infections by maternal immunization. Curr Opin Infect Dis. 2006;19(3):271-276. (Pubitemid 43740366)
36. Dworkin MS, Ward JW, Hanson DL, Jones JL, Kaplan JE; Adult and Adolescent Spectrum of HIV Disease Project. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis. 2001;32(5):794-800. (Pubitemid 32221939)
37. O'Brien KL, Wolfson LJ, Watt JP, et al; Hib and Pneumococcal Global Burden of Disease Study Team. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893-902.
38. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J. 2004;23(11):985-989. (Pubitemid 40824285)
39. Centers for Disease Control and Prevention (CDC). Pertussis - United States, 2001-2003. MMWR Morb Mortal Wkly Rep. 2005;54(50):1283-1286.
40. Knuf M, Schmitt H-J, Wolter J, et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr. 2008;152(5):655-660, 660, e1.
41. Englund JA, Anderson EL, Reed GF, et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics. 1995;96(3 pt 2):580-584.